By: Devin Sefton, Senior Associate Attorney, Braumiller Law Group The ever-shifting sands of U.S. sanctions and export controls can make it challenging to know the current
The U.S. sanctions and export controls is complex and can be easy to overlook certain fundamental considerations with respect to restriction.
Although 2020 is not over yet (unfortunately), the Bureau of Industry and Security (“BIS”) has had a busy year by any measure.
The ongoing COVID-19 crisis has presented unique challenges for the U.S. supply chain, and for the U.S. economy as a whole. Front and center is the shortage of critical medical equipment and personal protective equipment (“PPE”), including ventilators, respirators, masks, gloves, swabs and other related equipment.
Since the emergence of COVID-19 in the U.S. beginning in February of 2020, there is general uncertainty over how the pandemic could affect the regulatory landscape, including regulations relating to U.S. sanctions and export controls. A review of the actions taken to date suggest that little has changed with respect to U.S. economic sanctions.
